Nelson Jeffrey Edward — SEC Form 4 filings

SEC reporting owner CIK 1943112. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-05.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-01-29 to 2026-02-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Milestone Pharmaceuticals Inc. (MIST)Chief Operating Officer42 legs · 70,252 sh · $158,2099

Form 4 filings — Nelson Jeffrey Edward

FiledFormIssuerReported transactionsSource
2026-02-054/AMilestone Pharmaceuticals Inc. (MIST)Grant/award (A): 204,000 (derivative) @ $0EDGAR
2026-02-044Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 204,000 (derivative) @ $0 · Grant/award (A): 136,000 (derivative) @ $0EDGAR
2026-01-284Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 100,000 · Sale (S): 58,007 @ $2.32 · Option exercise (M): 20,100 · Sale (S): 12,245 @ $1.93 · Grant/award (A): 100,000 (derivative) @ $0 · Option exercise (M): 20,100 (derivative) @ $0EDGAR
2025-01-294Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 120,600 (derivative) @ $0 · Grant/award (A): 80,400 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1943112 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →